Search

everythinglearnresearchcommunity

for

Search:↓

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

P-SLN nanoparticles effectively deliver podophyllotoxin to the skin.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Drugs like PDEI may help hair disorders like AGA.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Lignans from Urtica triangularis may help treat benign prostatic hyperplasia (BPH).

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Plumbagin may help protect cells, reduce inflammation, and has potential for treating various diseases, but more research is needed.

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Nanoparticles may improve treatment for lung disease by targeting cells better and reducing side effects.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

PRP injections may improve hair thickness and density in female hair loss patients.

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.